Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease: The LoDoCo2 Trial
Publication date
2025-03-04
Authors
van der Bijl, Marte F.
van der Veen, Jenny
Fiolet, Aernoud T.L.
Boersma, Eric
Cornel, Jan H.
Eikelboom, John W.
Nidorf, Stefan M.
Thompson, Peter L.
Jannink, Jalina
Westendorp, Iris C.D.
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Keywords
cardiovascular disease, coronary disease, sex differences, women, Cardiology and Cardiovascular Medicine
Citation
van der Bijl, M F, van der Veen, J, Fiolet, A T L, Boersma, E, Cornel, J H, Eikelboom, J W, Nidorf, S M, Thompson, P L, Jannink, J, Westendorp, I C D, Mosterd, A, Den Den Ruijter, H M & Roeters van Lennep, J E 2025, 'Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease : The LoDoCo2 Trial', Journal of the American Heart Association, vol. 14, no. 5, e040412. https://doi.org/10.1161/JAHA.124.040412